Niue vs Northern Europe: Proportion of the target population who received a 3rd dose of
Niue
99.0%
in 2024
Northern Europe
89.0%
in 2024
Niue rank
1st
Northern Europe rank
2nd
Proportion of the target population who received a 3rd dose of over time
- Niue
- Northern Europe
How they compare
Niue currently reports 99.0% against 89.0% in Northern Europe, a difference of 10.0%.
That makes Niue's figure about 1.1 times Northern Europe's.
Across all 16 years both countries report, Niue has been ahead every year.
Niue ranks 1st and Northern Europe ranks 2nd of 157 countries.
Niue has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Niue | Northern Europe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 99.0% | 18.0% | 81.0% | Niue |
| 2010s | 99.0% | 89.1% | 9.9% | Niue |
| 2020s | 99.0% | 89.4% | 9.6% | Niue |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Niue or Northern Europe?
- Niue, at 99.0% against 89.0% in Northern Europe as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Niue and Northern Europe?
- 10.0%, with Niue ahead.
- How many years of comparable data are there for Niue and Northern Europe?
- 16 years are reported by both, from 2009 to 2024.
- How do Niue and Northern Europe rank globally for proportion of the target population who received a 3rd dose of?
- Niue ranks 1st and Northern Europe ranks 2nd of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.